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Introduction
Acute diarrhoea remains a leading cause of childhood
deaths despite the undeniable success of oral rehydration
therapy (ORT). Worldwide, diarrhoeal diseases are the
leading cause of paediatric morbidity and mortality, with
1.5 billion episodes and 1.5-2.5 million deaths estimated
annually among children below five years of age.1
Much of the success achieved in the control of diarrhoeal
morbidity and mortality has been conventionally
attributed to two therapeutic interventions: the oral
rehydration solution (ORS) and zinc supplementation.2 In
1992, the Centre for Disease Control (CDC) reported the
first national guideline, emphasising the emergency of
the treatment of childhood diarrhoea and the importance
of zinc supplementation. Since then, a variety of trials
have been done, especially in developing countries, to
assess the effect of zinc supplementation on the duration
and severity of diarrhoea.3
Despite these improvements, mortality due to diarrhoea
in developing countries remains too high. Zinc is used in
tablet or suspension forms, both preparations have the
same zinc sulphate monohydrate formulation, but
different efficacy, which was first observed in 2005 after
an earthquake in northern areas of Pakistan. After the
earthquake a massive number of children developed
diarrhoea due to poor hygiene in camps, and zinc was
available there in both forms for diarrhoea management.
There was the improvement with the treatment of zinc,
but there was difference in the efficacy level between zinc
tablet and suspension.4
The current study was planned to evaluate the difference
in children below 5 years of age.
Patients and Methods
The comparative study was carried out at the Liaquat
University Hospital, Hyderabad, Pakistan from October
2008 to April 2009, and comprised children aged 6-24
months suffering from acute diarrhoea. The sample size
was calculated by taking level of significance 5%, power of
study 80%, P1 39%,5 P2 13%.6 The sample was picked
using non probability purposive sampling.
Acute diarrhoea was defined as passage of three or more
semi-liquid stools in the preceding 24 hours, and not
containing blood and mucus. Those excluded were cases
of parental diarrhoea, diarrhoea with sepsis, severely
malnourished child, acute dysentery, failure to produce
consent.
All the paediatric patients who were admitted with
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Abstract
Objective: To compare the effectiveness of zinc supplementation in tablet form with that of the suspension form in
the treatment of acute diarrhoea.
Methods:A comparative studywas carried out at the Liaquat University Hospital, Hyderabad, Pakistan fromOctober
2008 to April 2009, and comprised children aged6-24 months suffering from acute diarrhoea. The patients were
divided into two groups on the basis of even and odd numbers. Group A (even numbers) received dispersible zinc
tablets, and group B (odd numbers) received zinc suspension. The patients were admitted for 3 days and
improvement was checked at the end of 3rd day in terms of decrease in the frequency of stools/day. SPSS 15 was
used for data analysis.
Results: The 88 patients were divided into two groups of 44(50%) each. Overall, 49(55.7%) patients were male and
39(44.3%) were female. At the end of the 3rd day 51(58%) patients improved, while 37(42%) did not. In the zinc
tablet group, improvement was in 32(72%) patients compared to 19(43%) in the zinc suspension group
(p<0.05).diarrhoea
Conclusion: The results of tablets preparation were clinically significant in reducing the duration and severity of
diarrhoea.
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history of acute diarrhoea were enrolled in the study after
taking informed consent from the parents/caregivers. A
questionnaire was developed for data collection. The
questionnaire was first pre-tested and then implemented.
Detailed history and examination were recorded on a
proforma.
The patients were divided into two groups on the basis of
even and odd numbers. Group A (even numbers) received
dispersible zinc tablets, and group B (odd numbers)
received zinc suspension with a dose of 20mg/day as per
the World Health Organisation (WHO) protocol for
diarrhoea.4 The patients were admitted for 3 days and
improvement was checked at the end of the 3rd day in
terms of decrease in frequency of stools (<3 stools/day).
Data analysis was done using SPSS 15. Qualitative and
quantitative variables were presented asmean ± standard
deviation (SD), while qualitative variables like gender and
effectiveness were presented as frequencies and
percentages. Chi square test was used to compare the
effectiveness of the two zinc formulations between the
groups. P<0.05 was considered significant.
Results
The 88 patients were divided into two groups of 44(50%)
each. Overall, 49(55.7%) patients were male and
39(44.3%) were female. Of the total, 39(44.3%) patients
were 6-12 months of age, and of them 18(46%) were on
tablets and 21(54%) were on suspension form. Besides,
49(55.7%) patients were aged 13-24 months, and of them
26(53%) were on tablets and 23(47%) were on suspension
form.
At the end of the 3rd day 51(58%) patients improved,
while 37(42%) did not (Table-1).
In the zinc tablet group, improvement was in 32(72%)
patients compared to 19(43%) in the zinc suspension
group (p<0.05) (Table-2).
Discussion
Zinc is one of the most important micronutrients in the
human diet, and it is crucial for many cell functions, such
as protein synthesis and cell growth and differentiation.7
Zinc's mechanism of action for the treatment of diarrhoea
caused by different pathogens is not fully understood, but
studies conducted in this field reveal that zinc plays
different roles in the intestine, such as regulation of
intestinal fluid transport and mucosal integrity and
modulation of expression of genes encoding important
zinc-dependent enzymes like cytokines, which play
important roles in the immune system and in modulation
of oxidative stress (OS).8 These different roles might
explain the positive effect of zinc intake during acute
diarrhoea in children.
The current study was conducted to document the better
effectiveness of zinc supplementation in tablets or
suspension form as an adjunct to ORT and early
continued feeding among pre-school children with acute
diarrhoea. It shows clinically important and statistically
significant overall reduction of 72% in the risk of
continued diarrhoea with zinc tablets compared to 43%
with zinc suspension with 95% confidence interval (CI) for
tablets group (0.326-1.762) and for suspension group
(0.757-1.736). Another longitudinal cohort study was
conducted4 among children to measure the impact of
daily zinc administration in different formulations. About
90% of the patients recovered from diarrhoea within 3
days of presentation; 82% from tablet group and 96%
from the suspension (p= 0.001).
Therefore, a considerable effect of zinc on the duration
and frequency of diarrhoea was found in both groups, but
more favourably in the suspension group.
Zinc tablets, however, are cheaper and dose
measurement is more accurate than in suspension form,
and there is no need for teaching the mother about
having to shake the suspension before use or proper
measurement by spoon. Only 10-day course of zinc
tablets are sufficient for decreasing the frequency of
diarrhoea and diarrhoea-related morbidity and mortality.
Our results suggest tablet form of zinc is more effective in
the treatment of acute diarrhoea. But more controlled
studies are needed to establish better evidence in favour
of zinc tablets.
Conclusion
Zinc tablets resulted in clinically significant reduction in
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Table-1: Decreased frequency of diarrhoea within 24 hour.
Frequency Percent
<3 Stools Per Day 51 58.0
3 Or More Stools Per Day 37 42.0
Table-2: Comparison of effectiveness of zinc at the end of 3rd day between the
treatment groups.
Comparison of Effectiveness of the p-value
Zinc at the end of 3rd day between
the Treatment Group
Treatment group Effective Not effective 1.1.1
Tablets 32 (72%) 12 (27%) 1.1.2
Suspension 19 (43%) 25 (56.8%) 1.1.3
Total 51 (57%) 37 (42%) < 0.005
the duration and severity of diarrhoea than the zinc
suspension form.
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